跳至主要内容
临床试验/NCT00647231
NCT00647231已完成2 期

Protocol HKT-500-US12: A Randomized, Multicenter, Double-Blind, Single Dose Study of the Analgesic Properties of HKT-500 and Placebo in Subjects With Pain Caused by Mild to Moderate Osteoarthritis of the Knee

Hisamitsu Pharmaceutical Co., Inc.1 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2008年3月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
300
试验地点
1
主要终点
Time to Onset and Duration

研究概览

简要总结

The objective of this study is to characterize the analgesic properties of single dose study of HKT-500 in subjects with pain caused by mild to moderate OA of the knee

详细描述

A Randomized, Multicenter, Double-Blind, Single Dose Study of the Analgesic Properties of HKT-500 and Placebo in Subjects with Pain Caused by Mild to Moderate Osteoarthritis of the Knee

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Factorial
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
45 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • male or female 45 years of age or older
  • with osteoarthritis of the knee

排除标准

  • subject is a woman of childbearing potential
  • who has a positive urine pregnancy test,
  • is lactating, or who is not surgically sterile

研究组 & 干预措施

A, 2, II, HKT-500 Topical Patch

Experimental

A Randomized, Multicenter, Double-Blind, Single Dose Study of the Analgesic Properties of HKT-500 and Placebo in Subjects With Pain Caused by Mild to Moderate Osteoarthritis of the Knee

干预措施: HKT-500 Topical Patch (Drug)

Placebo Patch

Placebo Comparator

Treatment with placebo patch

干预措施: Placebo Patch (Other)

结局指标

主要结局

Time to Onset and Duration

时间窗: 36 hours

次要结局

  • Outcome Time Frame(36 hours)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验